Air Street Capital

Fern Labs is a technology company focused on developing AI-based agent interfaces. Their platform aims to coordinate networks of agents within organizations, enabling users to work more efficiently, innovate faster, and tackle complex problems. The company's mission is to ensure that the current era of computing serves a higher purpose, with a focus on building intelligent, safe, and secure context systems.

Sereact is a developer of artificial intelligence-based robotics focused on transforming warehouse operations and e-commerce fulfillment processes. The company specializes in creating adaptable AI systems that enable intelligent robot-assisted picking of various items, aimed at enhancing automation and operational efficiency. By providing advanced software tools, Sereact assists clients in automating their workflows, ultimately leading to increased productivity and reduced operational costs. The company's innovative approach addresses critical automation gaps within the logistics sector, positioning it at the forefront of the next generation of intelligent robotic solutions.

Odyssey operates as an AI start-up, provides hollywood-grade visual AI.

Profluent Bio is an artificial intelligence-driven protein design company focused on creating innovative proteins that overcome existing industry challenges. The company integrates advanced generative AI models with real-world laboratory characterization to optimize protein development. By employing machine learning techniques, Profluent Bio is able to read and write biomolecules, facilitating advancements in both human health and industrial applications. This approach supports biotechnology research and aims to enhance the effectiveness of protein-based solutions across various sectors.

Interloom Technologies redefines process automation for an AI future.

Intenseye Inc. is a technology company based in San Jose, California, specializing in an AI-powered video analytics platform designed to enhance health and safety in workplace environments. Founded in 2018, Intenseye's platform utilizes advanced computer vision and machine learning to analyze real-time video feeds from existing cameras, enabling clients to monitor workplace conditions continuously. The system provides automated inspections and immediate notifications of safety violations, such as improper use of personal protective equipment or hazardous behaviors. By focusing on privacy, Intenseye ensures that the visual data processed does not include personally identifiable information. The company's solutions are particularly beneficial for large enterprises seeking to improve employee safety while minimizing accidents and operational errors.

CellVoyant Technologies Limited is an innovative biotechnology company founded in 2021, focused on developing advanced stem cell-based therapies to address chronic diseases. The company employs an AI-first approach, utilizing live cell imaging technology to predict and optimize stem cell differentiation, which allows for the scalable and precise manufacturing of any human cell and tissue. CellVoyant's technology is rooted in pioneering research from the Carazo Salas lab at the University of Bristol, merging expertise in cell biology, computer vision, engineering, and machine learning. Led by Founder and CEO Rafael Carazo, the company aims to translate cutting-edge scientific advancements into real-world applications, addressing critical healthcare challenges. With a commitment to transforming the biotechnology landscape, CellVoyant is positioned to deliver effective, life-changing therapies to patients globally.

Delian Alliance Industries is a seed-stage company focused on developing autonomous technology aimed at addressing national security challenges within the EU and its allies. By infusing the military industry with the innovative culture of venture-capital-funded startups, the company is creating a framework for future platforms dedicated to civil defense and protection. Delian Alliance Industries has developed an advanced autonomous surveillance system that utilizes artificial intelligence to enhance mission-critical applications, reconnaissance, and situational awareness. This system analyzes, fuses, and geolocates diverse sensor data in real-time, allowing defense and civil engineers to integrate information from various sources, such as cameras and radars, into a coherent operational view.

Sereact is a developer of artificial intelligence-based robotics focused on transforming warehouse operations and e-commerce fulfillment processes. The company specializes in creating adaptable AI systems that enable intelligent robot-assisted picking of various items, aimed at enhancing automation and operational efficiency. By providing advanced software tools, Sereact assists clients in automating their workflows, ultimately leading to increased productivity and reduced operational costs. The company's innovative approach addresses critical automation gaps within the logistics sector, positioning it at the forefront of the next generation of intelligent robotic solutions.

Poolside is an artificial intelligence platform that offers foundation concepts and infrastructure. It aims to unlock humanity's potential by pursuing AGI for software creation, with the fundamental belief that the transitional path for humanity to AGI is by building specific capabilities instead of a general-purpose approach. It also helps users utilize the power of software creation and understand future systems.

V7 Ltd is a London-based company established in 2018 that specializes in developing a comprehensive platform for computer vision AI training data. The company focuses on providing high-quality annotated data for images, videos, documents, and medical imaging files, enabling businesses to train their AI models effectively. V7's platform includes advanced features such as auto-labeling, quality assurance, and tools for team collaboration that significantly reduce data annotation time. By allowing seamless integration with existing technology stacks, V7 facilitates efficient management of machine learning operations and provides users with full control over their models and datasets through its open API and SDK. The company's solutions are designed to enhance the accuracy and speed of AI development, making it easier for organizations to implement and utilize computer vision technologies.

Hedera Dx is a healthcare company established on July 1, 2021, in Epalinges, Vaud, specializing in liquid biopsy solutions aimed at enhancing cancer detection and treatment. The company's innovative system enables hospital laboratories to perform clinically useful liquid biopsies independently, simplifying the process of tumor profiling. By addressing challenges related to compliance, privacy, and validation, Hedera Dx offers a streamlined experience for clinicians, facilitating early detection, therapy selection, and monitoring of cancer recurrence. This technology not only aids in reducing cancer risks but also presents opportunities to lower mortality rates and healthcare costs.

Profluent Bio is an artificial intelligence-driven protein design company focused on creating innovative proteins that overcome existing industry challenges. The company integrates advanced generative AI models with real-world laboratory characterization to optimize protein development. By employing machine learning techniques, Profluent Bio is able to read and write biomolecules, facilitating advancements in both human health and industrial applications. This approach supports biotechnology research and aims to enhance the effectiveness of protein-based solutions across various sectors.

Anagenex is a seed stage biotechnology company that specializes in drug discovery, focusing on challenging medical targets. The company has developed an innovative platform that significantly accelerates the discovery of small molecule drugs and the identification of pharmaceutical compounds. By utilizing machine learning in conjunction with DNA-encoded libraries, Anagenex's technology can rapidly analyze a vast number of compounds, generating extensive data sets and conducting parallel biochemical experiments. This capability is enhanced by proprietary artificial intelligence models, which facilitate the development of new therapeutic drugs aimed at addressing critical medical needs.

Athenian is a software platform designed for engineering leaders, enabling them to enhance team alignment and drive continuous improvement within their organizations. By quantifying bottlenecks and measuring growth, Athenian's tools provide insights into workflows, processes, and productivity challenges. The platform helps users identify key success indicators, optimize software delivery, and improve communication across teams. Athenian focuses on fostering a shared understanding among team members, moving beyond individual metrics to create a collaborative environment that encourages ongoing development and efficiency. Through its innovative solutions, Athenian supports organizations in building a culture of continuous improvement, ultimately contributing to greater profitability and operational effectiveness.

Gandeeva Therapeutics is a precision biotechnology company focused on developing innovative therapeutics by leveraging cryogenic electron microscopy and machine learning to target and modulate key protein-protein interactions. The company employs a comprehensive structure-guided drug discovery platform that includes target prediction and validation, hit identification from virtual and fragment libraries, and lead optimization. Gandeeva's preclinical oncology pipeline is designed to address challenging cancers through the creation of novel protein interaction modulators, specifically interfacial glues and allosteric inhibitors. Headquartered in the Greater Vancouver area, Canada, Gandeeva Therapeutics aims to enhance treatment options and reduce the risks of late-stage clinical failures in oncology.

Anagenex is a seed stage biotechnology company that specializes in drug discovery, focusing on challenging medical targets. The company has developed an innovative platform that significantly accelerates the discovery of small molecule drugs and the identification of pharmaceutical compounds. By utilizing machine learning in conjunction with DNA-encoded libraries, Anagenex's technology can rapidly analyze a vast number of compounds, generating extensive data sets and conducting parallel biochemical experiments. This capability is enhanced by proprietary artificial intelligence models, which facilitate the development of new therapeutic drugs aimed at addressing critical medical needs.

InVivo AI is a Montreal-based company founded in 2017 that specializes in leveraging artificial intelligence to enhance pharmaceutical research and development, with a particular focus on preclinical toxicology. The company has developed advanced AI methods for molecular representation, structure and ligand-based de novo design, and multiparameter optimization, enabling the creation of novel chemistry to address complex biological challenges.

Intenseye Inc. is a technology company based in San Jose, California, specializing in an AI-powered video analytics platform designed to enhance health and safety in workplace environments. Founded in 2018, Intenseye's platform utilizes advanced computer vision and machine learning to analyze real-time video feeds from existing cameras, enabling clients to monitor workplace conditions continuously. The system provides automated inspections and immediate notifications of safety violations, such as improper use of personal protective equipment or hazardous behaviors. By focusing on privacy, Intenseye ensures that the visual data processed does not include personally identifiable information. The company's solutions are particularly beneficial for large enterprises seeking to improve employee safety while minimizing accidents and operational errors.

Modern Intelligence is a technology company based in San Jose, California, founded in 2020. It focuses on developing advanced artificial intelligence solutions specifically for the defense sector. By leveraging proprietary advancements in information and complexity theory, Modern Intelligence employs a hierarchical approach that provides significant scaling advantages over traditional neural networks. This approach enables high accuracy in few-shot learning, allowing the company to tackle novel problems and address challenges that were previously deemed unsolvable. Additionally, Modern Intelligence has developed a maritime sensor platform that accelerates the integration of AI within military operations. This platform enhances military hardware and command systems by enabling them to track, analyze, and learn from maritime targets during missions, such as drug interdiction and fleet combat, thereby improving decision-making capabilities with minimal data requirements.

Gourmey is a pioneering cultivated meat company based in Paris, France, founded in 2019. It specializes in the development and production of ethical foie gras derived from duck cells, aiming to revolutionize the traditional foie gras industry. By utilizing a lab-based approach, Gourmey cultivates meat without the need for force-feeding or slaughter, ensuring a more humane and sustainable alternative. The company places duck cells in a controlled environment, providing optimal temperature, essential nutrients, and space for growth, which results in a product that prioritizes consumer health, environmental sustainability, and animal welfare.

Intenseye Inc. is a technology company based in San Jose, California, specializing in an AI-powered video analytics platform designed to enhance health and safety in workplace environments. Founded in 2018, Intenseye's platform utilizes advanced computer vision and machine learning to analyze real-time video feeds from existing cameras, enabling clients to monitor workplace conditions continuously. The system provides automated inspections and immediate notifications of safety violations, such as improper use of personal protective equipment or hazardous behaviors. By focusing on privacy, Intenseye ensures that the visual data processed does not include personally identifiable information. The company's solutions are particularly beneficial for large enterprises seeking to improve employee safety while minimizing accidents and operational errors.

V7 Ltd is a London-based company established in 2018 that specializes in developing a comprehensive platform for computer vision AI training data. The company focuses on providing high-quality annotated data for images, videos, documents, and medical imaging files, enabling businesses to train their AI models effectively. V7's platform includes advanced features such as auto-labeling, quality assurance, and tools for team collaboration that significantly reduce data annotation time. By allowing seamless integration with existing technology stacks, V7 facilitates efficient management of machine learning operations and provides users with full control over their models and datasets through its open API and SDK. The company's solutions are designed to enhance the accuracy and speed of AI development, making it easier for organizations to implement and utilize computer vision technologies.

Allcyte is a biotech start-up specializing in functional drug testing using primary human materials. The company has developed a high-content imaging platform known as Pharmacoscopy, which incorporates AI-supported image analysis to assess drug effects at the single-cell level. This technology closely simulates in vivo conditions, allowing for a realistic preview of drug efficacy in actual patients. Allcyte's mission is to advance personalized medicine for cancer treatment by providing physicians and pharmaceutical companies with critical insights to prioritize the most suitable drugs for specific indications. By minimizing sample manipulation and employing sophisticated statistical and machine learning techniques, Allcyte aims to enhance biomedical decision-making and optimize cancer treatment outcomes.

LabGenius Ltd is a biopharmaceutical company based in London, United Kingdom, focused on discovering and developing new protein therapeutics to address unmet medical needs, including conditions like Inflammatory Bowel Disease. Founded in 2012, the company utilizes a machine learning-driven evolution engine and a robotic platform known as EVA, which is capable of designing, conducting, and learning from its own experiments. This innovative approach integrates advanced technologies from synthetic biology, robotics, and machine learning, enabling the engineering of protein drugs with enhanced properties such as protease stability and tissue penetration. By leveraging these cutting-edge methodologies, LabGenius aims to provide physicians with access to novel protein therapeutics that are developed through automation and intelligent design.

Mission Barns, Inc. is a biotechnology company based in Berkeley, California, founded in 2018. It specializes in the production of cell-cultured meat by cultivating animal cells in a nutrient-rich environment. By utilizing cellular agriculture techniques, Mission Barns aims to create sustainable meat products that minimize the negative impacts associated with traditional intensive animal farming. The company focuses on growing meat in a way that is efficient and environmentally friendly, allowing consumers to enjoy juicy and savory meats while contributing to a more sustainable food system.

Vtrus is a technology company focused on advancing robotics through its development of the Autonomy Brain Implant (ABI), a modular system designed to enhance robotic understanding of their environment. This innovative system simplifies the complexities of perception, planning, and control, allowing developers to efficiently initiate robotics projects. Additionally, Vtrus has created autonomous inspection drones equipped with advanced sensors, including cameras, thermal imagers, and three-dimensional scanners. These drones facilitate the automatic collection of crucial data for monitoring industrial facilities, generating comprehensive 3D maps with geo-anchored media to improve post-inspection analysis. By enabling data collection in previously inaccessible locations and reducing the risks associated with hazardous environments, Vtrus enhances operational efficiency for various industries.

Mission Barns, Inc. is a biotechnology company based in Berkeley, California, founded in 2018. It specializes in the production of cell-cultured meat by cultivating animal cells in a nutrient-rich environment. By utilizing cellular agriculture techniques, Mission Barns aims to create sustainable meat products that minimize the negative impacts associated with traditional intensive animal farming. The company focuses on growing meat in a way that is efficient and environmentally friendly, allowing consumers to enjoy juicy and savory meats while contributing to a more sustainable food system.

Hedera Dx is a healthcare company established on July 1, 2021, in Epalinges, Vaud, specializing in liquid biopsy solutions aimed at enhancing cancer detection and treatment. The company's innovative system enables hospital laboratories to perform clinically useful liquid biopsies independently, simplifying the process of tumor profiling. By addressing challenges related to compliance, privacy, and validation, Hedera Dx offers a streamlined experience for clinicians, facilitating early detection, therapy selection, and monitoring of cancer recurrence. This technology not only aids in reducing cancer risks but also presents opportunities to lower mortality rates and healthcare costs.